Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 1796094, 8 pages
http://dx.doi.org/10.1155/2016/1796094
Research Article

Low-Dose Steroid Therapy Is Associated with Decreased IL-12 Production in PBMCs of Severe Septic Patients

1Division of Pulmonary, Critical Care and Sleep Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan
2Chang Gung University College of Medicine, Taoyuan 333, Taiwan
3Department of Emergence, Chang Gung Memorial Hospital, Keelung 204, Taiwan
4Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan
5Division of Cardiology, Chang Gung Memorial Hospital, Keelung 204, Taiwan

Received 5 February 2016; Revised 18 June 2016; Accepted 3 July 2016

Academic Editor: Constantino López-Macías

Copyright © 2016 Huang-Pin Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Sepsis syndromes: understanding the role of innate and acquired immunity,” Shock, vol. 16, no. 2, pp. 83–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Reddy, G. H. Chen, P. K. Tekchandani, and T. J. Standiford, “Sepsis-induced immunosuppression: from bad to worse,” Immunologic Research, vol. 24, no. 3, pp. 273–287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” The New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. E. J. Giamarellos-Bourboulis, I. Dimopoulou, A. Kotanidou et al., “Εx-vivo effect of dexamethasone on cytokine production from whole blood of septic patients: correlation with disease severity,” Cytokine, vol. 49, no. 1, pp. 89–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Oppert, R. Schindler, C. Husung et al., “Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock,” Critical Care Medicine, vol. 33, no. 11, pp. 2457–2464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Critical Care Medicine, vol. 36, no. 1, pp. 296–327, 2008. View at Google Scholar
  7. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Publisher · View at Google Scholar
  8. R. P. Dellinger, J. M. Carlet, H. Masur et al., “Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock,” Critical Care Medicine, vol. 32, no. 3, pp. 858–873, 2004. View at Google Scholar
  9. C. L. Sprung, D. Annane, D. Keh et al., “Hydrocortisone therapy for patients with septic shock,” The New England Journal of Medicine, vol. 358, no. 2, pp. 111–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Casserly, H. Gerlach, G. S. Phillips et al., “Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign,” Intensive Care Medicine, vol. 38, no. 12, pp. 1946–1954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. Miller III, L. Dong, N. C. Nelson et al., “Multicenter implementation of a severe sepsis and septic shock treatment bundle,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 1, pp. 77–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. P. Patel and R. A. Balk, “Systemic steroids in severe sepsis and septic shock,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 2, pp. 133–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-P. Wu, C.-C. Shih, C.-Y. Lin, C.-C. Hua, and D.-Y. Chuang, “Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors,” Critical Care, vol. 15, no. 5, article R224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Russell, “Management of sepsis,” New England Journal of Medicine, vol. 355, no. 16, pp. 1699–1713, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar
  16. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Keh, T. Boehnke, S. Weber-Cartens et al., “Immunologic and hemodynamic effects of ‘low-dose’ hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 512–520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Zhou, R. Somasundaram, R. F. Nederhof et al., “Impact of human granulocyte and monocyte isolation procedures on functional studies,” Clinical and Vaccine Immunology, vol. 19, no. 7, pp. 1065–1074, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Söderberg, M. Lipcsey, J. Sjölin, A. Larsson, and M. B. Eriksson, “Counteraction of early circulatory derangement by administration of low dose steroid treatment at the onset of established endotoxemic shock is not directly mediated by TNF-α and IL-6,” Steroids, vol. 77, no. 11, pp. 1101–1106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. M. Jules-Elysee, J. Y. Lipnitsky, N. Patel et al., “Use of low-dose steroids in decreasing cytokine release during bilateral total knee replacement,” Regional Anesthesia and Pain Medicine, vol. 36, no. 1, pp. 36–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Briegel, M. Jochum, C. Gippner-Steppert, and M. Thiel, “Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses,” Journal of the American Society of Nephrology, vol. 12, no. 17, pp. S70–S74, 2001. View at Google Scholar · View at Scopus
  23. S. Hodge, G. Hodge, R. Flower, and P. Han, “Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood,” Scandinavian Journal of Immunology, vol. 49, no. 5, pp. 548–553, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Yeager, P. A. Pioli, K. Wardwell et al., “In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes,” Anesthesia and Analgesia, vol. 107, no. 5, pp. 1726–1734, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Asadullah, C. Woiciechowsky, W. D. Döcke et al., “Very low monocytic HLA-DR expression indicates high risk of infection—immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy,” European Journal of Emergency Medicine, vol. 2, no. 4, pp. 184–190, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. J. W. Haveman, A. P. van den Berg, J. M. M. van den Berk et al., “Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake,” Transplant Infectious Disease, vol. 1, no. 3, pp. 146–152, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. L. Tulzo, C. Pangault, L. Amiot et al., “Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 10, pp. 1144–1151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. R. Bornstein, H. Rutkowski, and I. Vrezas, “Cytokines and steroidogenesis,” Molecular and Cellular Endocrinology, vol. 215, no. 1-2, pp. 135–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Stanilova, Z. T. Karakolev, G. S. Dimov et al., “High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors,” Intensive Care Medicine, vol. 31, no. 3, pp. 401–407, 2005. View at Publisher · View at Google Scholar · View at Scopus